Prevalence and Associated Predictors of Hypertension in Adult Patients with Thyroid Nodules at the Royal Commission Hospital, Kingdom of Saudi Arabia

Ahmed M Khair¹, Mona A Sid Ahmed¹, Faisal H Alharbi¹, Soha hassan¹, Nusaiba M Elbadwi¹, Sami Naji Almutairi¹, Imad R Musa^1*

¹Royal Commission Hospital at AL Jubail Industrial City, Al Jubail, Kingdom of Saudi Arabia

*Corresponding author: Imad R Musa, Royal Commission Hospital at AL Jubail Industrial City, Al Jubail, Kingdom of Saudi Arabia.

Received: 05 January 2023; Accepted: 19 January 2023; Published: 23 January 2023

Abbreviations:

KSA- Kingdom of Saudi Arabia; DM- Diabetes Mellitus.; T2DM- Type 2 Diabetes Mellitus;T1DM- Type 2 Diabetes Mellitus TNs- Thyroid Nodules.; FT4- Free Thyroxine; FT3- Free Triiodothyronine; T3- Hormone Triiodothyronine; T4- Thyroxine; TSH- Thyroid-Stimulating Hormone; 25(OH)D- 25-hydroxyvitamin D; LDL- Low-Density Lipoprotein; HDL- High-Density Lipoprotein; AOR- Adjusted Odds Ratio; IQR- Interquartile Range; kg- kilogram; m- Meter; cm- Centimeter; BMI- Body Mass Index; CI- Confidence Interval; SD- Standard Deviation; ACR TI- RADS- American College of Radiology Thyroid Imaging Reporting and Data System.

Introduction

Thyroid nodules (TNs) are a common clinical problem detected in approximately 5% to 7% of the adult population through physical examination alone. A very high prevalence (50%) of TNs larger than 1 cm in patients without previously diagnosed thyroid disease has been documented in autopsy data [1,2]. Although more than 90% of the detected nodules are clinically insignificant benign lesions [2], TNs are clinically important as they represent thyroid cancer in approximately 4.0% to 6.5% of cases [3]. Moreover, thyroid cancer has emerged as the most common endocrine cancer worldwide, with an incidence of 56 cases per 100,000 [4]. It is also the fifth most common cancer in women and the second most common among those older than 50 years [5]. Currently, TNs are diagnosed more frequently with the use of modern imaging modalities, such as ultrasound, computed tomography (CT), magnetic resonance imaging and positron emission tomography [6]. Likewise, the fine needle aspiration report and scoring systems of thyroid ultrasound are essential tools for evaluating TNs with reliable diagnostic accuracy and prognostic importance [7]. One of the most important risk factors is exposure to ionizing radiation in some environments, along with female gender, age, diabetes mellitus (DM), hypertension and genetics [8–11]. Hypertension is the leading preventable risk factor for cardiovascular disease and all-cause mortality worldwide [12]. A higher prevalence of hypertension among adults has been reported in low- and middle-income countries (31.5%) compared with high-income countries (28.5%) [13]. From 2000 to 2010, the prevalence of hypertension increased by 7.7% in low- and middle-income countries, while it decreased by 2.6% in high-income countries [14]. The associations between TNs and hypertension have been reported in different countries [15–18]. Recently published data from the Kingdom of Saudi Arabia (KSA) have shown higher prevalence of hypertension and prehypertension in the Saudi population [19–21]. In addition, ahigher prevalence has been observed in males compared with females and in the urban compared with the rural population [20,21]. According to the Saudi Heart Association, the economic cost of managing hypertension and its related cardiovascular complications in the KSA is a rapidly growing financial burden that increased from $3.5 billion in 2016 and will likely reach $9.8 billion by 2035 [22]. Meanwhile, thyroid gland disorders are the most common endocrine abnormalities in the KSA and the Middle East region [23,24]. Moreover, a high prevalence of TNs has been reported in the Saudi population (34%–40%) [25,26], along with an increased rate of thyroid cancer (11.7%) [27]. Given the importance of the two abovementioned clinical entities, the potential coexistence of both conditions and the dearth of published data on the topic in the region, the current study aimed to investigate the prevalence of hypertension in adult patients with TNs at the Royal Commission Hospital in the eastern region of the KSA.

2. Methods

A retrospective study was conducted at the Royal Commission Hospital from 1 January 2015 to 31 December 2021. The files of adult patients (men and women) aged 18 years and older with documented TNs based on the findings of an ultrasound procedure were retrieved. The ultrasound procedures were conducted in the radiology department of the hospital. Each thyroid ultrasound procedure was performed in the radiology department by a radiology specialist, and each report was reviewed and approved by a radiology consultant. Thyroid ultrasound reports based on the American College of Radiology Thyroid Imaging Reporting and Data System (TI- RADS) were adopted to assess the TNs (Table 1) [28]. Medical records with incomplete data and thyroid ultrasound reports for thyroid ultrasounds conducted in other hospitals were excluded. Finally, 391 patients with TNs were recruited for this study. The socio-demographic data, including each patient’s age, sex, weight, height, thyroid status and common co-morbidities (type   1 DM and type 2 DM, hypertension and bronchial asthma) were gathered using a data collection sheet. Moreover, laboratory tests for haematological indices (white blood cell count, haemoglobin and platelet count), thyroid function, lipid profiles and vitamin D levels were collected.

Table 1: (TI-RADS) Category definitions.

TI-RADS, thyroid imaging reporting and data system.

2.1 Definition of Variables

2.1.1 Thyroid Nodules: TNs were diagnosed according to the ACR TI-RADS classification criteria for risk assessment of malignant TNs [28].

2.1.2 Body Mass Index (BMI): BMI was calculated as the body mass divided by the square of the body height; it is expressed in units of kg/m², resulting from mass in kilograms and height in metres.

2.1.3 Hypertension: This variable included patients known to be hypertensive and receiving treatment according to their medical records during the time the thyroid ultrasound was conducted.

2.1.4 DM: This variable includes those who had documentation of DM (type 1 and 2), whether they were on diet control or glucose-lowering drugs during the time of the thyroid ultrasound procedure.

2.1.5 Bronchial Asthma: This variable included patients diagnosed with bronchial asthma based on their medical records around the time of the thyroid ultrasound procedure.

2.1.6 Vitamin D Deficiency: This variable was defined as a 25-hydroxyvitamin D (25[OH]D) level of < 30 ng/mL; levels equal to or above this cut-off point were considered normal [29].

2.2 Statistical Analysis

Data were analysed using SPSS for Windows (version 22.0). The Shapiro-Wilk test assessed the normality for continuous data; all variables were not normally distributed. Data were expressed as proportions, medians with interquartile ranges (IQRs) or numbers and proportions, as applicable. A univariate analysis was performed, with the diagnosed hypertension as the dependent variable. The independent variables were age, sex, BMI, thyroid status, DM, bronchial asthma, thyroid hormones, 25(OH)D level, haematological indices (haemoglobin, white blood cell count and platelet count), lipid profile and TI-RADS ultrasound score. A variable was analysed using logistic regression if its univariate P-value was < 0.20, and backward stepwise likelihood ratio regression was selected for adjustment. Odds ratios (ORs) and 95% confidence intervals (CIs) were computed, and P-values < 0.05 were considered significant.

3. Results

Three hundred ninety-one patients with documented TNs were recruited for the study. The median (IQR) for the patients’ age was 46.00 (20.0) years, and the majority were females (84.9%). The median (IQR) for the BMI and 25(OH)D level were 30.26 (7.71) kg/m² and 14.50 (12.0) nmol/L, respectively. The median (IQR) values for the thyroid hormones were as follows: thyroid-stimulating hormone (TSH), 1.72 (2.43) mmol/L; free thyroxine, 1.12 (0.45) ng/dL; and FT3, 2.69 (0.40) nmol/L. While most participants had normal thyroid functions (64%), a small percentage of patients had either hypothyroidism (28.6%) or hyperthyroidism (7.4%). The median (IQR) for total cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL) and triglycerides were 5.80 (3.89) mmol/L, 3.76 (0.80) mmol/L, 2.99 (1.71) mmol/L and 1.78 (1.11) mmol/L, respectively. The median (IQR) values for the haematological indices were as follows: white blood cell count, 7.01 (2.63) 10⁹/L; haemoglobin, 12.60 (1.7) gm/dl; and platelet count, 276.15 (95.8) 10³/dl. The patients’ percentages according to the TI-RADS ultrasound scores (1,2, 3, 4 and 5) were 2.6%, 18.4%, 40.7%, 36.3% and 2%, respectively (Table 2). There was a high prevalence of hypertension (22.5%) in adult patients with TNs.

Table 2: general characteristics of adult patients with thyroid nodules in eastern region 2015-2021.

In the univariate analysis, there was no association between diagnosed hypertension in adult patients with TNs and BMI, 25(OH)D level, thyroid status, haematological indices (white blood cell count, haemoglobin and platelet), LDH, triglycerides, TSH, FT4 and thyroid ultrasound based on the TI-RADS scoring system. However, there were significant associations between diagnosed hypertension in adult patients with TNs and age (OR = 1.099 [95% CI 1.073 - 1.127]), sex (OR = 3.14 [95% CI 1.750 - 5.634]), DM (OR = 0.160 [95% CI 0.095 - 0.27]), bronchial asthma (OR = 0.495 [95% CI 0.227 - 1.077]), FT3 (OR = 0.666 [95% CI 0.468 - 0.948]), total cholesterol (OR= 0.645 [95% CI 0.559 - 0.745]) and HDL (OR = 0.420 [95% CI 0.316 - 0.558]), Table 3).

Table 3: Univariate analysis of the factors associated with hypertension in adult patients with thyroid nodules in eastern region 2015- 2021.

IQR- Interquartile Range; OR- Odds Ratio; CI- Confidence Interval.

In the multivariate analysis, bronchial asthma, FT3 and HDL were not significantly associated with diagnosed hypertension in adult patients with thyroid nodular diseases. However, there were significant associations between hypertension in adult patients with TNs and age (OR = 1.076 [95% CI 1.048 - 1.105], P < 0.000), sex (OR = 2.28 [95% CI 1.132 - 4.591], P = 0.002), DM (OR = 0.316 [95% CI 0.175 - 0.573], P = 0.040) and total cholesterol levels (OR = 0.820 [95% CI 0.694 - 0.969], P = 0.020) (see Table 4).

Table 4: Multivariate analysis of the factors associated with hypertension in adult patients with thyroid nodules eastern region 2015- 2021.

IQR- Interquartile Range; OR- Odds Ratio; CI- Confidence Interval

4. Discussion

The current study documented a higher prevalence of hypertension (22.5%) in adults with thyroid nodular diseases in the KSA. The prevalence of hypertension in patients with TNs in this study was higher than that obtained recently in the KSA (16.8%) [18] and slightly lower than that reported in Turkey (26.9%) [17]. Surprisingly, a very high prevalence of hypertension in a similar group of patients was demonstrated in China (45.6%) [30], particularly in the Daxing District of Beijing (60.37%) [31] and those with advanced age (69.8%) (mean age =102.8±2.8 years) [32]. It is worth mentioning that a higher prevalence of untreated hypertension (62.7%) compared with treated hypertension (56.1%) was documented in the Chinese population with TNs in Beijing, China [31]. The significant association between hypertension and the presence of TNs has been reported in many studies in different countries across the globe, such as the KSA [18], Turkey [15,17], China [11,16,30–33], Korea 34 and Japan [35,36]. The higher prevalence of hypertension obtained in patients with TNs may be attributed to the higher prevalence of hypertension reported recently in the KSA (37.5%) [19]. Likewise, a report in 2007 from the KSA showed a higher prevalence of hypertension in males (28.6%) versus females (23.9%) and in rural (22.4%) versus urban (27.9%) population [21]. Additionally, a higher prevalence of prehypertension was documented recently among Saudi men (47.2%) and women (24.7%) [20]. The high prevalence of hypertension in our study was in concordance with the global rise in the prevalence of hypertension in low- and middle-income countries (31.5%) and with the higher prevalence of hypertension in high- income countries (28.5%), despite being decreased by 2.6% [13]. Interestingly, a family history of hypertension was noted in 26.9% of patients with TNs [32]. G-protein-coupled receptor kinases (GRKs) are implicated in the pathophysiology of arterial hypertension and thyrotropin receptor (TSHR). Their role in the pathophysiology of hyperfunctioning TNs can be promoted as the explanation for the association of hypertension and thyroid nodular diseases [37]. Another extrapolation regarding this association is that the high level of aldosterone concentration and the presence of aldosterone synthase expression suggest that aldosterone may be locally produced and secreted in thyroid tissues from cystic nodules [38]. Similarly, recently published data from Japan underscored a significant positive association between thyroid cysts and hypertension [35] and systolic hypertension [36], indicating a higher thyroid hormone activity in thyroid cysts [35]. The current study showed older age as a significant predictor of the presence of hypertension in adult patients with TNs. Similar significant associations of age and hypertension in the same group of participants have been documented recently in many published studies [15,16,30,31,33,34], in line with the results of previous research revealing that the higher prevalence of hypertension and TNS are associated with increased age [15,32,34,39]. This may be linked to inflammation, the most consistently documented biological feature of aging, which entails higher inflammatory markers [39]. Moreover, the higher prevalence of hypertension and TNs have been associated with the prevalence of a wide range of age-related co-morbidities, such as cardiovascular co-morbidities [40], insulin resistance and DM [41]. On the other hand, the degeneration of thyroid cells reflects the age-related changes in the thyroid gland, leading to fibrosis, infiltration of inflammatory cells, thyroid follicle alteration and thyroid nodular diseases [42]. Our study and other studies worldwide have shown the higher prevalence of TNs among females and demonstrated that the female sex is a significant predictor of hypertension in adult patients with TNs [15,16,30,34]. This may be explained by the effects of oestrogen that promotes the growth of thyroid stem cells and progenitor cells, leading to the proliferation of thyroid stem cells and TN formation through different mechanisms (e.g. classical genomic and non-genomic pathways) [43,44]. A study in 2018 from the United States demonstrated an increase in hypertension prevalence and associated cardiovascular complications among females [45]. Moreover, the gender difference has been well established in the prevalence of hypertension: women accounted for approximately 51% of the hypertensive population based on the Seventh/Eighth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7/8) Guidelines using the National Health and Nutrition Examination Survey (NHANES) blood pressure data from 2011–2014 [45]. Likewise, after menopause, women display a more rapid increase in the prevalence of hypertension compared with men, eventually exceeding that seen in men at age 75 and above [45]. In this study, the presence of DM is a highly significant predictor of hypertension in adult patients with thyroid nodular diseases. This was strengthened by the results of many clinical trials documenting that both DM and hypertension are positively and significantly associated with TNs [10,11,15,17,30,31,33,34]. Moreover, the risk of getting any of the three co- morbidities (hypertension, DM and TNs) increases with aging [32,40,41]. Furthermore, aging promotes TN formation with the risk of associated metabolic syndrome [10,30,31], insulin resistance and high levels of insulin-like growth factor-1 [11,41]. Our study and many other studies have found that a higher level of total cholesterol is a significant predictor of the presence of hypertension in adult patients with TNs [10,16,31,34,46], indicating the positive and significant association of the components of metabolic syndrome and the formation of TNs associated with insulin resistance, insulin-like growth factor-1 and high level of inflammatory markers [10,11,46]. Moreover, a high level of total cholesterol can predict the risk of thyroid cancer [47]. Recently, some studies have indicated that cholesterol influences the signal pathway of growth factor receptors in tumour cells, inducing an abnormal pathological signal and causing carcinogenesis [47]. Likewise, cholesterol may potentiate increased tumour angiogenesis and proliferation and reduced apoptosis of tumour cells [48]. The results of the present study are in accordance with the outcomes of many studies that have documented the lack of significant associations between TNs and other associated predictors (thyroid hormones, thyroid status, haematological indices, vitamin D levels and the TI-RADS scoring system) [11,49,50].

5. Limitation

This study was retrospective and involved only one centre. Other factors, such as thyroid antibodies, iodine levels, blood pressure control, duration of hypertension, nutritional patterns, smoking, alcohol consumption, exposure to radiation, genetic analysis and environmental factors, were not assessed.

6. Conclusion

There is a high prevalence of hypertension in adult patients with thyroid nodular disease. Age, female sex, DM and a high level of total cholesterol are significant predictors of hypertension in patients with TNs in the eastern region of the KSA.

Declarations

Ethical Approval and Consent to Participate

The study was approved by the ethical committee of the Royal Commission Hospital, KSA (IB- RCH-012) that waived the verbal or written consent from the participants.

Consent for Publication

Not applicable.

Availability of Data and Materials

Upon request, please contact the corresponding author (I R.Musa).

Competing Interest

The authors declare that they have no competing interests.

Funding

The authors received no financial support for the research, authorship and/or publication of this article.

Author Contributions

Conceptualization: IRM, AMK &MAS. Methodology: FHA, NME, SH & SNA Data Curation FHA, MAS, SH, SNA & NME. Formal Analysis: IRM, & AMK. Investigation: FHA, SNA, SH AMK & NME. Writing – Original Draft Preparation: IRM, MAS and AMK. All contributors reviewed the manuscript.

Acknowledgments

Not applicable.

Contributor Information

Ahmed M.Khair1, Royal Commission Hospital at AL Jubail Industrial City, Al Jubail, Kingdom of Saudi Arabia, Ahmed1982249@gmail.com ORCID iD: https://orcid.org/0000-0002-3469-873X

Mona A Sid Ahmed1, Royal Commission Hospital at AL Jubail Industrial City, Al Jubail, Kingdom of Saudi Arabia, mona79sawi@gmail.com, ORCID iD: https://orcid.org/0000-0002-4338-8637

Faisal H Alharbi 1 Royal Commission Hospital at AL Jubail Industrial City, Al Jubail, Kingdom of Saudi Arabia, doctorfaisal1994@gmail.com. ORCID iD: https://orcid.org/0000-0001-6476-7882.

Soha hassan1 Royal Commission Hospital at AL Jubail Industrial City, Al Jubail, Kingdom of Saudi Arabia, Sohahassan2006@hotmail.com. ORCID iD: https://orcid.org/0000-0002-3469-873X.

Nusaiba M Elbadwi1 .Royal Commission Hospital at AL Jubail Industrial City, Al Jubail, Kingdom of Saudi Arabia, Nusaiba0682@outlook.com. ORCID iD: https://orcid.org/0000-0001-5231-1765

Sami Naji Almutairi1 Royal Commission Hospital at AL Jubail Industrial City, Al Jubail, Kingdom of Saudi Arabia Dr.Sami.Naji@gmail.com. ORCID iD: https://orcid.org/0000-0003-2650-5229

Imad R Musa1. Royal Commission Hospital at AL Jubail Industrial City, Al Jubail, Kingdom of Saudi Arabia, irthesudanese@hotmail.com , ORCID iD: https://orcid.org/0000-0002-1138-0710

References

1. Bomeli SR, LeBeau SO, Ferris RL. Evaluation of a thyroid nodule. Otolaryngol Clin North Am 43 (2010): 229-238.
2. Durante C, Costante G, Lucisano G, et al. The natural history of benign thyroid nodules. JAMA 313 (2015): 926-935.
3. Popoveniuc G, Jonklaas J. Thyroid nodules. Med Clin North Am 96 (2012): 329-349.
4. Li J, Wang Q, Wang L, et al. Diagnostic value of fine-needle aspiration combined with ultrasound for thyroid cancer. Oncol Lett 18 (2019): 2316.
5. Vaccarella S, Dal Maso L. Challenges in investigating risk factors for thyroid cancer. lancet Diabetes Endocrinol 9 (2021): 57-59.
6. Pemayun TGD. Current Diagnosis and Management of Thyroid Nodules. Acta medica Indonesiana 48 (2016): 247-257.
7. Pandya A, Caoili EM, Jawad-Makki F, et al. Retrospective Cohort Study of 1947 Thyroid Nodules: A Comparison of the 2017 American College of Radiology TI-RADS and the 2015 American Thyroid Association Classifications. AJR Am J Roentgenol 214 (2020): 900-906.
8. Khodamoradi F, Ghoncheh M, Mehri A, et al. Incidence, Mortality, and Risk Factors of Thyroid Cancer in the World: a Review. World cancer Res J 5 (2018): 1093.
9. Liu Y, Su L, Xiao H. Review of Factors Related to the Thyroid Cancer Epidemic. Int J Endocrinol (2017).
10. Liu Y, Lin Z, Sheng C, et al. The prevalence of thyroid nodules in northwest China and its correlation with metabolic parameters and uric acid. Oncotarget 8 (2017): 41555-41562.
11. Du X, Liu Y, Zhao C, et al. Changes of serum 25(OH) D3 and IGF-1 levels in patients with thyroid nodules. BMC Endocr Disord (2019).
12. Stanaway JD, Afshin A, Gakidou E, et al. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet (London, England) 392 (2018): 1923-1994.
13. Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol 16 (2020): 223-237.
14. Mills KT, Bundy JD, Kelly TN, et al. Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-based Studies from 90 Countries. Circulation 134 (2016): 441.
15. Ayturk S, Gursoy A, Kut A, et al. Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine- deficient area. Eur J Endocrinol 161 (2009): 599-605.
16. Guo H, Sun M, He W, et al. The prevalence of thyroid nodules and its relationship with metabolic parameters in a Chinese community-based population aged over 40 years. Endocrine 45 (2014): 230-235.
17. Bener A, Özdenkaya Y, Barisik CC, et al. The Impact of Metabolic Syndrome on Increased Risk of Thyroid Nodules and Size. Heal Serv Res Manag Epidemiol 5 (2018): 233339281877551.
18. Elaggan A, Mostafa A, Albdair R, et al. The Value of Ultrasonography Using Thyroid Imaging Reporting and Data Systems (TIRADS) in the Diagnosis of Thyroid Cancer Among the Population of Ha’il, Saudi Arabia. Cureus 14 (2022).
19. Al-Hanawi MK, Keetile M. Socio-Economic and Demographic Correlates of Non- communicable Disease Risk Factors Among Adults in Saudi Arabia. Front Med 8 (2021).
20. Al-Raddadi R, Al-Ahmadi J, Bahijri S, et al. Gender Differences in The Factors associated with Hypertension in Non-Diabetic Saudi Adults-A Cross-Sectional Study. Int J Environ Res Public Health 18 (2021).
21. Al-Nozha MM, Abdullah M, Arafah MR, et al. Hypertension in Saudi Arabia. Saudi Med J 28 (2007): 77-84.
22. Gagnon-Arpin I, Habib M, AlAyoubi F, et al. Modelling the burden of cardiovascular disease in Saudi Arabia and the impact of reducing modifiable risk factors. J Saudi Hear Assoc 30 (2018): 365.
23. Saad Al Shahrani A, El-Metwally A, Al-Surimi K, et al. The epidemiology of thyroid diseases in the Arab world: A systematic review. J Public Heal Epidemiol Full Length Res Pap 8 (2016): 17-26.
24. Refeidi AA, Al-Shehri GY, Al-Ahmary AM, et al. Patterns of thyroid cancer in Southwestern Saudi Arabia. Saudi Med J 31 (2010): 1238-1241.
25. Elzaki A, Osman H. The prevalence of thyroid nodules among Saudi radiography technicians. Medical Science 25 (2021): 3017-3023.
26. Al-Shammari MA, Abdel Wahab MM, AlShamlan NA, et al. Clinical, Laboratory, and Ultrasound Related Diagnoses of Thyroid Disorders: Using a Family Medicine Center Data to Assess Thyroiditis and Thyroid Nodules in the Eastern Province of Saudi Arabia. J Prim Care Community Health 13 (2022).
27. Bazarbashi S, Al Eid H, Minguet J. Cancer Incidence in Saudi Arabia: 2012 Data from the Saudi Cancer Registry. Asian Pac J Cancer Prev 18 (2017): 2437-2444.
28. Tessler FN, Middleton WD, Grant EG, et al. ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee. J Am Coll Radiol 14 (2017): 587-595.
29. Alzaheb RA. The Prevalence of Hypovitaminosis D and Its Associated Risk Factors Among Women of Reproductive Age in Saudi Arabia: A Systematic Review and Meta- Analysis. Clin Med insights Women’s Heal 11 (2018): 1179562X1876788.
30. Xu L, Zeng F, Wang Y, et al. Prevalence and associated metabolic factors for thyroid nodules: a cross-sectional study in Southwest of China with more than 120 thousand populations. BMC Endocr Disord 21 (2021).
31. Zheng L, Yan W, Kong Y, et al. An epidemiological study of risk factors of thyroid nodule and goiter in Chinese women. Int J Clin Exp Med 8 (2015): 11379.
32. Yao Y, Chen X, Wu S, et al. Thyroid nodules in centenarians: prevalence and relationship to lifestyle characteristics and dietary habits. Clin Interv Aging 13 (2018): 515-522.
33. Feng S, Zhang Z, Xu S, et al. The Prevalence of Thyroid Nodules and Their Association with Metabolic Syndrome Risk Factors in a Moderate Iodine Intake Area. Metab Syndr Relat Disord 15 (2017): 93-97.
34. Moon JH, Hyun MK, Lee JY, et al. Prevalence of thyroid nodules and their associated clinical parameters: a large-scale, multicenter-based health checkup study. Korean J Intern Med 33 (2018): 753-762.
35. Shimizu Y, Kawashiri SY, Noguchi Y, et al. Association between thyroid cysts and hypertension by atherosclerosis status: a cross-sectional study. Sci Reports 11 (2021): 1-9.
36. Shimizu Y, Nabeshima-Kimura Y, Kawashiri SY, et al. Associations between thyroid- stimulating hormone and hypertension according to thyroid cyst status in the general population: a cross-sectional study. Environ Health Prev Med 25 (2020).
37. Voigt C, Holzapfel HP, Meyer S, et al. Increased expression of G-protein-coupled receptor kinases 3 and 4 in hyperfunctioning thyroid nodules. J Endocrinol 182 (2004): 173-182.
38. Greenman Y, Trostanetsky Y, Ben-Shemen S, et al. Thyroid cysts: a new extra-adrenal site of aldosterone synthase expression and increased aldosterone content. Clin Endocrinol (Oxf) 66 (2007): 886-889.
39. Buford TW. Hypertension and aging. Ageing Res Rev 26 (2016): 96-111.
40. Cesari M, Penninx BWJH, Newman AB, et al. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation 108 (2003): 2317-2322.
41. Bertoni AG, Burke GL, Owusu JA, et al. Inflammation and the incidence of type 2 diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care 33 (2010): 804-810.
42. Saad AG, Kumar S, Ron E, et al. Proliferative activity of human thyroid cells in various age groups and its correlation with the risk of thyroid cancer after radiation exposure. J Clin Endocrinol Metab 91 (2006): 2672-2677.
43. Derwahl M, Nicula D. Estrogen and its role in thyroid cancer. Endocr Relat Cancer 21 (2014): T273-T283.
44. Manole D, Schildknecht B, Gosnell B, et al. Estrogen promotes growth of human thyroid tumor cells by different molecular mechanisms. J Clin Endocrinol Metab 86 (2001): 1072-1077.
45. Ramirez LA, Sullivan JC. Sex Differences in Hypertension: Where We Have Been and Where We Are Going. Am J Hypertens 31 (2018): 1247-1254.
46. Liu J, Wang C, Tang X, et al. <p>Correlation analysis of metabolic syndrome and its components with thyroid nodules</p>. Diabetes, Metab Syndr Obes Targets Ther 12 (2019): 1617-1623.
47. Zhao J, Tian Y, Yao J, et al. Hypercholesterolemia Is an Associated Factor for Risk of Differentiated Thyroid Cancer in Chinese Population. Front Oncol 10 (2021).
48. Cruz P, Torres C, Ramírez ME, et al. Proliferation of human mammary cancer cells exposed to 27-hydroxycholesterol. Exp Ther Med 1 (2010): 531-536.
49. Musa IR, El Khatim Ahmad M, Al Raddady FS, et al. Predictors of a follicular nodule (Thy3) outcome of thyroid fine needle aspiration cytology among Saudi patients. BMC Res Notes 10 (2017).
50. Alyousif H, Alamin NA, Ahmed MAS, et al. Prevalence of Vitamin D Deficiency and the Associated Risk Factors in Adults with Thyroid Nodule in Royal Commission Hospital, Kingdom of Saudi Arabia. Int J Innov Res Med Sci 7 (2022): 304-310.